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Conclusions: IMRT with 8 fields is the best technique to obtain the 
goals of the optimization. VMAT can be used when the 'PTV length-
lung length' ratio is low. Tomotherapy doesn’t allow to maintain an 
acceptable PTV coverage if the ratio is high. 
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Purpose/Objective: APBI with external beam RT (EBRT) has emerged 
in the recent years as a treatment option for selected patients with 
early stage breast cancer. Some studies demonstrated the feasibility 
of using volumetric modulated arc therapy (VMAT) for APBI as away to 
improve PTV dose conformity and to deliver lower doses to the 
ipsilateral lung and breast as compared to the conventional 3D-CRT 
techniques. Separately, multiple studies have confirmed the 
effectiveness of breath hold techniques in reducing the cardiac dose 
for left sided breast cancer treated with EBRT. In the search of an 
optimal APBI treatment procedure, we investigate the use of VMAT 
(RapidArc®) and/or voluntary moderately deep inspiration breath hold 
(vmDIBH) in patients treated with external beam APBI.  
Materials and Methods: Three patients were included in this study. 
For each patient 2 CT scans were made, one in free breathing (FB) 
and one in vmDIBH. In each scan, five different tumours were 
contoured in the left breast: upper inner, upper outer, central, lower 
inner, and lower outer. On each CT scan, a conventional 3D-CRT and a 
RapidArc® plan were made using the Varian EclipseTM treatment 
planning system, leading to 60 combinations of patient, tumour site 
and technique. Dose parameters for the PTV, heart, lungs, breasts 
were compared for all plans.  
Results: Preliminary results of this ongoing study show that the 
highest cardiac doses were observed in 3D-CRT plans combined with 
FB for tumors located in the lower inner part of the breast [mean dose 
3.7 ± 0.7 Gy]. With vmDIBH these values were reduced to 1.8± 0.3 Gy. 
The heart volume receiving > 5Gy (V5Gy) was reduced to 7.8% for 
RapidArc® plans in vmDIBH compared with 24.7% and 14.7% in 3D-CRT 
plans in FB and with vmDIBH respectively. For other tumour positions, 
the mean heart dose ranged from 0.2 Gy to 1.3 Gy in FB, which is 
always slightly reduced using vmDIBH to a maximum of 0.5 Gy in all 
plans. RapidArc® plans in breath hold also slightly decreased the 
ipsilateral lung doses [V5Gy= 12.6% ± 1.2%] compared to 3D-CRT 
plans[V5Gy = 15.8% ± 7.3%]. The fraction of the non-target part of the 
ipsilateral breast receiving 50% of the prescribed dose or more was on 
average reduced by 30% in RapidArc® plans as opposed to 3D-CRT 
plans. While, no dose was given to the contralateral breast in 3D-CRT 
plans, RapidArc® plans showed a slight increase in the low dose [V5Gy = 
2.3% ± 0.6%]. In all RapidArc®plans the dose conformity was better 
compared with that of 3D-CRT plans [CI =0.9 ± 0.05 vs. 0.7 ± 0.08]. 
Conclusions: APBI with RapidArc® offers good PTV dose conformity 
and delivers lower doses to lungs and ipsilateral breast compared to 
3D-CRT. This has been at the cost of slightly higher volumes of 
contralateral breast receiving low dose radiation. Patients with 
tumours in the lower inner part of the breast are most likely to 
benefit from combined VMAT and breath hold techniques.  
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Purpose/Objective: Although a lot of tools are available in modern 
treatment planning systems to evaluate 3D dose distributions (DVH, 
biological indices, isodoses in arbitrary planes), the optimality of a 
given IMRT/VMAT plan still depends mainly on the experience of the 
planner and on the way that the optimization problem has been 
formulated in terms of dose objectives. To overcome this bias, we 
have implemented a system that uses our experience in IMRT 
optimization to predict final organ-at-risk (OAR) dose based on 
individual patient geometry. With this technique, we can detect and 
evaluate deviations between predicted and planner results, or 
automatically generate plans with OAR doses consistent with our past 
clinical experience. 
Materials and Methods: In this study we focused on prostate cancer. 
We reviewed all photon IMRT/VMAT plans treated in the past two 
years and found that the final equivalent uniform dose (EUD) for 
bladder and rectum showed a strong linear correlation with the 
overlap volume with the PTV. We used the overlap volume to predict 
plan optimization objectives for rectum and bladder EUD. These 
actions were implemented by user-scripting in our treatment planning 
system (Philips Pinnacle3). This automated technique was applied on 
23 patients to be treated for a prostate cancer in our institution. 
Results: Although they respected clinical goals, significant deviations 
between the operator's final plan and the automated plan (EUD>2Gy) 
were observed in 6 cases indicating non-optimal plans in comparison 
to our past experience. This approach permitted to reduce by half in 
average the planning time, mainly be reducing the number of manual 
iterations loops which are often needed to achieve good quality plans. 
Conclusions: The implementation of this experience-based IMRT 
quality control step has shortened the treatment planning time and 
enables us to easily detect bad optimizations compared to previously 
treated plans. The planner has now the ability to quickly evaluate 
quality of its plan incomparison to previously treated plans. We plan 
to extend this approach to other clinical sites. 
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Purpose/Objective: Increasing the dose delivered via IMRT planning; 
specifically patient specific dose escalation is of current clinical 
interest in improving local control and in turn survival in NSCLC 
patients. Dose escalation usually requires a plan to be created for 
each feasible prescription until an OAR constraint can not be met or a 
plan is optimised using the maximum prescription. To identify the 
optimum prescription for a patient requires a significant amount of 
planning time and the manual creation of multiple redundant plans. 
This study aims to investigate the effectiveness of an automated IMRT 
planning technique in reducing the planning time required by 
minimising the number of plans being created manually.  
Materials and Methods: The automated planning system is operated 
using an in house written java program. Constraints used for inverse 
plan optimisation in Pinnacle v9.0 are iteratively changed using the 
java program. The resulting plan is compared against a static group of 
evaluation objectives to ensure suitability. Clinically relevant 
constraints chosen for optimisation are placed into several levels of 
precedence. Tumour coverage is given the initial priority followed by 
serial organ near-max doses. Once a suitable plan is created the 
system increases the prescription dose and the optimisation is 
repeated using the constraints from the previous iteration as a 
starting point. Figure 1 demonstrates the process used by the system. 
The initial prescription dose of 55.8Gy is increased by adding 
additional fractions of 1.8Gy. The treatment schedule is bi-daily over 
a 4 week period. Dose escalation continues until a maximum 
prescription dose of 79.2Gy is achieved or an OAR objective cannot be 
met. This technique was evaluated by applying it to 5 NSCLC patients. 
Evaluation objectives were selected from an isotoxic lung feasibility 
study. In addition to the evaluation of the dose statistics using a plan 
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assessment form the planned isodose coverage was reviewed for 
clinical suitability. 
 
  
Results: Dose escalation was possible for all patients above 55.8Gy. 
Upon evaluation all serial OAR are within tolerance. The 'one size fits 
all' approach of the same set of starting constraints for all patients 
creates varying degrees of success in terms of 90% isodose coverage. 
Increased dose prescriptions created more inhomogeneous 
distributions. For each possible prescription the system outputs the 
optimised constraints to allow for an informed choice in terms of the 
final prescription dose to be used. The automated method took on 
average 4-6 hours to complete the process.  
Conclusions: The automated dose escalation planning system shows 
promise as a tool for reducing the time required to carry out isotoxic 
lung planning. The plans produced all met the objectives given to the 
system. The system creates plans that are an excellent starting point 
for a planner to create a clinically acceptable plan.  
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Purpose/Objective: The interest in radiotherapy treatment planning 
which incorporates metabolic information obtained by non-invasive 
tumour imaging, and the consequent capability of targeting the 
identified biological regions with the appropriate radiation doses, has 
increased the interested in dose-painting techniques. These 
approaches, by which the dose distribution is modified to take into 
account the local characteristics of the tumour, generally require 
specific inverse-planning engines where the 'biological' properties 
associated with each individual target voxel are considered into the 
optimization phases. Since such devices are not yet present on the 
market, two methods based on a commercial treatment planning 
system (TPS) together with an external bio-optimization tool (TaBio) 
were applied and compared. 
Materials and Methods: The best theoretical dose for each voxel of 
the target, as a function of the corresponding signal intensity maps of 
the biological tumor imaging analyzed, has been realized. To achieve 
this goal, an homemade inverse-planning tool was realized where 
objective functions (TCP - tumor control probability and EUD - 
equivalent uniform dose) can be selected to guide the target integral 
dose (kept constant) redistribution. The dose patterns obtained were 
then reprocessed in two different ways. In the first case, geometric 
structures have been realized by matching the shapes of some isodose 
levels opportunely selected. In the second case instead, the 
calculated doses have been inverted to create specific dose moulds. 
Both these objects have been so exported to a TPS (Eclipse, Varian) 
and used as dose maps gold standard to be replicated. The critical-
organ dose constraints were added in the optimization process, while 
for the second method, a uniform target dose distribution was 
required in addition. Five patients have been simulated to verify these 
two approaches, where the Standard Uptake Values of Fluoro-Choline 
(PET/CT) imaging has been used as a surrogate marker for their 
prostate tumor clonogen-densities. 
Results: Although neither planning approach was able to replicate the 
theoretical biologically estimated dose maps, the dose contour's based 
method has proved to be the most accurate in reaching 'acceptable' 
dose patterns. Since the TCP-based optimizations generally result in 
dose maps which are more heterogeneous (mean coefficient of dose 
variation CV = 6.8%) and with larger voxel-dose ranges than the EUD-
based optimizations (CV = 4.6%), such solutions deviating most from 
the theoretical. The use of EUD-based optimization would seem to be 
the easiest way to follow. 
Conclusions: Being able to include, on a voxel-based scale, the 
Fluoro-Choline PET data into the dose optimization process, the 
method of dose-contours seems more able to yield acceptable and 
deliverable dose-painting treatment plans. 
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Purpose/Objective: The purpose of this study is twofold: first it aims 
at exploring the effectiveness of a linear programming approach for 
finding beamlet's weights in IMRT; secondly it aims at investigating the 
usefulness of the so obtained solution as a qualified starting point for 
a further non linear IMRT optimization.  
Materials and Methods: In IMRT treatment planning the goal is to find 
an optimal compromise between organ at risk (OAR) sparing and 
target coverage: given a prescription, one needs to ?nd a beamlet 
intensity vector so that the calculated dose from it will satisfy the 
prescription as closely as possible. We solved a linear programming 
(LP) optimization problem to minimize the deviation in dose from a 
prescribed dose on target and the maximum dose allowed on OARs. 
The choice of a linear programming approach was due to the easiness 
of formulating and solving the problem.for large treatment plans. To 
set up simulated treatment, we used the research treatment planning 
system CERR (computational environment for radiotherapy research) 
based on the MATLAB environment. One brain and one prostate cancer 
patient were selected for 7 field IMRT treatment optimisation. For 
these case we investigated the effectiveness of the beamlet solution 
obtained by solving the LP problem and the usefulness of using that 
solution, as a starting point for gEUD based optimization. In fact, 
gEUD based optimization is non convex and may result in multiple 
local minima, therefore the choice of a starting point is crucial. The 
LP approach has been finally compared with the dosimetric 
optimization based on the weighted least squares objective function 
used in the routine Operation-Research-Application in Radiation-
Therapy (ORART) of CERR. 
Results: We found that LP solution exhibits an improved sparing of 
normal tissues and a better target coverage than the one obtained 
with ORART. The figure shows the comparison of DVHs of a brain plan 
with dosimetric optimization with ORART (solid lines) and with the LP 
approach (dashed lines). The PTV54 and PTV60 represents the two 
different planning target volumes treated with 54 GY and 60 Gy 
respectively. Besides supplying a good treatment plan, LP solution 
gives an improvement (both in terms of DVHs and gEUD values) in 
gEUD based optimization when used as a starting point.  
For example, we found for the brain plan, an improvement on the 
gEUD values: 14.14 versus 16.41 for right optic tracts and 25.6 versus 
